资讯
Natco Pharma, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹826.85. The stock has experienced fluctuations today, with a low ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
NATCO Pharma Share Price: NATCO Pharma shares on Thursday crashed 20 per cent to hit the lower circuit after poor Q3 results FY2025. NATCO Pharma shared opened gap down with a cur of nearly 14 per ...
来自MSN8 个月
Natco Pharma share price hits 52-week high after 90% rally year to date. Buy, Sell or Hold?Stock Market Today: Natco Pharma share price gained more than 7% to scale 52-week highs on Thursday, The Natco Pharma share price has gained more than 90% year to date. The strong performance in ...
The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, it has crashed 44.42 per cent on a year-to-date (YTD) basis.
Natco Pharma Limited is a vertically ... of 1 crore Equity Shares at the issue price of Rs 915 per Equity (including a premium of Rs. 913 per Equity Share) upon the closure of the issue, to ...
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b ...
The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to ...
The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.
12-Feb-25 18-Feb-25 18-Feb-25 1.5 Rs.1.5000 per share(75%)Third Interim Dividend 12-Nov-24 27-Nov-24 27-Nov-24 1.5 Rs.1.5000 per share(75%)Second Interim Dividend (RD & XD dates revised ...
Nifty Pharma has fallen by 12.8 per cent so far this year, with Natco Pharma and Granules India leading the plunge ...
Trump Tariffs Impact, Indian Pharma stocks & share price updates: Nifty Pharma index soared over 4% in early trade before settling 2% higher, despite equity indices recording modest losses due to US ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果